Pengfei Yu

机构：Suzhou Traditional Chinese Medicine Hospital · ORCID：0000-0003-4702-2648

发表论文 180 篇 · 总被引 4241 次 · h-index 32

代表论文

• LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway (2024 · Journal of Experimental & Clinical Cancer Research · 被引 19)
• Celastrol Regulates the Hsp90-NLRP3 Interaction to Alleviate Rheumatoid Arthritis (2024 · Inflammation · 被引 12)
• Inflammation preservation strategy: reconciling pain control and disc resorption in lumbar disc herniation (2025 · Frontiers in Immunology · 被引 10)
• A decade-long study on pathological distinctions of resectable early versus late onset colorectal cancer and optimal screening age determination (2024 · Scientific Reports · 被引 7)
• Rational Design of the First Dual Agonist at Trace Amine-Associated Receptor 1 and 5-HT 2C Receptors Based on Binding Pocket Similarity for the Treatment of Schizophrenia and Alzheimer’s Disease-Related Psychosis (2025 · Journal of Medicinal Chemistry · 被引 6)
• Calcofluor White-Phosphatidylethanolamine Conjugate-Enhanced Ethosomal Delivery of Voriconazole for Targeting Candida albicans (2024 · International Journal of Nanomedicine · 被引 6)